959585-44-5 Usage
General Description
Methyl 2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)acetate is a complex compound consisting of methyl, acetate, pyrazole, and boron elements. It is often used in organic synthesis and chemical research, particularly in the creation of pharmaceuticals and agrochemicals. methyl 2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)acetate may have potential applications in the development of new drugs and materials due to its unique structure and properties. Additionally, its boron-containing moiety makes it valuable in catalysis and as a reagent in synthetic chemistry. Overall, this chemical has diverse potential uses and applications in various fields of science and industry.
Check Digit Verification of cas no
The CAS Registry Mumber 959585-44-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,9,5,8 and 5 respectively; the second part has 2 digits, 4 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 959585-44:
(8*9)+(7*5)+(6*9)+(5*5)+(4*8)+(3*5)+(2*4)+(1*4)=245
245 % 10 = 5
So 959585-44-5 is a valid CAS Registry Number.
InChI:InChI=1/C12H19BN2O4/c1-11(2)12(3,4)19-13(18-11)9-6-14-15(7-9)8-10(16)17-5/h6-7H,8H2,1-5H3
959585-44-5Relevant articles and documents
MAP4K4 INHIBITORS
-
Paragraph 00281, (2020/07/05)
This invention relates to compounds that may be useful as inhibitors of Mitogen-activated Protein Kinase Kinase Kinase Kinase-4 (MAP4K4). The invention also relates to the use of these compounds, for example in a method of treatmentof cardiac conditions.In particular, the present invention relates to compounds of formula (I):
AMINOPYRIDINE DERIVATIVES FOR TREATING TUMORS AND INFLAMMATORY DISEASES
-
Page/Page column 22, (2012/05/20)
Compounds of the formula (I), in which R1, R2, R3, R4, R7 and Y have the meanings indicated in Claim 1, are inhibitors of PDK1 and cell proliferation/cell vitality and can be employed for the treatmen
TRIAZOLOPYRIDAZINE DERIVATIVES
-
Page/Page column 32, (2008/06/13)
The invention relates to compounds of the formula (I) or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3 and R3' are as defined herein. The invention also relates to pharmaceutical compositions containing the compounds of formula (I) and to methods of treating hyperproliferative disorders in a mammal by administering the compounds of formula (I).